Skip to the page

Data / Form D filings / Morphic Holding, Inc.

Morphic Holding, Inc.: Form D filings

Morphic Holding, Inc., a biotechnology company in Waltham, MA, filed 3 Form D notices with the SEC between 2016 and 2023. The latest, on March 1, 2023, reports $100 million sold of a $100 million offering to 4 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
35 GATEHOUSE DRIVE A2, Waltham, MA, 02451
Phone
(978) 729-6480
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1679363

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 1, 2023New notice$100,000,000$99,999,755$2454Feb 15, 2023sec.gov
Oct 1, 2018New notice$79,999,990$79,999,99013Sep 17, 2018sec.gov
Jul 13, 2016New notice$51,500,000$20,599,999$30,900,00112Jun 29, 2016sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Susannah A. GrayDirector
Norbert BischofbergerDirector
Timothy A. SpringerDirector
Nisha P. NandaDirector
Joseph P. SlatteryDirector
William P. DeVaulExecutive Officer
Gustav A. ChristensenDirector
Bruce E. RogersExecutive Officer
Praveen P. TipirneniExecutive Officer, Director
Marc P. SchegerinExecutive Officer
Martin E. EdwardsDirector
Amir A. NashatDirector
Robert E. FarrellExecutive Officer

Other biotechnology companies in Massachusetts that filed recently

Every Form D from the week of Feb 27, 2023 · All recent filings in Massachusetts · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Morphic Holding, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.